Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 42

Results For "therapeutics"

576 News Found

Lonza launches new non-endotoxin pyrogen detection system
News | June 07, 2022

Lonza launches new non-endotoxin pyrogen detection system

The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics


ENPICOM launches versatile display data analysis solution to accelerate antibody selection
Biotech | May 25, 2022

ENPICOM launches versatile display data analysis solution to accelerate antibody selection

The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform


Merck KGaA to expand its membrane and filtration manufacturing facility in Ireland
News | May 23, 2022

Merck KGaA to expand its membrane and filtration manufacturing facility in Ireland

The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland


City of Hope and Imugene dose patient in Phase 1 trial to test cancer-killing oncolytic virus
Biotech | May 18, 2022

City of Hope and Imugene dose patient in Phase 1 trial to test cancer-killing oncolytic virus

City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours


Eight Roads announce US $ 250 million healthcare fund for India
News | May 17, 2022

Eight Roads announce US $ 250 million healthcare fund for India

This new fund is amongst the largest for the sector in India


University of Nebraska Medical Center and ANANDA Scientific announce USFDA approval
Biotech | May 17, 2022

University of Nebraska Medical Center and ANANDA Scientific announce USFDA approval

The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology


GeneQuantum Healthcare's two bioconjugate drugs approved for clinical trials in Australia
Biotech | May 16, 2022

GeneQuantum Healthcare's two bioconjugate drugs approved for clinical trials in Australia

They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights


WHO and MPP announce agreement with NIH for Covid-19 health technologies
Public Health | May 13, 2022

WHO and MPP announce agreement with NIH for Covid-19 health technologies

The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries


Jonathan Peacock elected Chairman of the Board of Directors of Avantor
People | May 13, 2022

Jonathan Peacock elected Chairman of the Board of Directors of Avantor

Peacock also serves as a Director and Chair of the Audit and Finance Committee of UCB SA, a biopharmaceutical company focusing on neurology and immunology